Powder Delivery TRIZ Cases

A PAMAM-coated silica nanoparticle links MDM2, GLUT1, and E3 ligands to cooperatively degrade both proteins and restore p53 activity.

Self-assembled PVA-SA nanoparticles improve mucoadhesion and prolong drug release while reducing doxorubicin side effects and tissue damage.

A Fe3O4-A12-Cy7 probe combines FLI, MPI, and CTA to improve early atherosclerotic plaque detection and continuous 3D monitoring.

Specific antibodies detect free symmetric dimethylarginine without complex LC-MS/MS or ELISA sample prep, shortening assay turnaround time.

A gelatin-silicate-tantalum hydrogel enables visible, catheter-delivered vessel embolization while reducing leakage, recanalization, and entrapment risks.

Selective beta adrenergic agonists cross the blood-brain barrier to improve cognition while peripheral β-blockers limit cardiac and metabolic effects.

Combining biodegradable polymers with cellulose-derived materials improves microsphere uniformity, drug entrapment, and sustained parenteral release.

A dual-strain probiotic approach reduces inflammatory cytokines, lowers oxidative stress, and strengthens the intestinal barrier without antibiotic resistance.

A pH 6+ cellulose-alginate nasal powder balances fast nicotine uptake with storage stability while reducing irritation, residue, and lung exposure.

Pure CBD isolate is crystallized into 1-100 micron aerosol particles to target the lungs and sinuses with cleaner respiratory delivery.

Low-molecular-weight PVP with arginine lowers viscosity in high-concentration protein formulations while preserving stability for easier manufacturing and injection.

Formula I conjugates improve tumor inhibition while reducing toxicity to normal cells through selective molecular structure and dosing.

Spray-dried nanocrystal microparticles reduce aggregation and tune particle size for lung deposition, raising local drug levels with fewer side effects.

Electrostatic bonding between positively charged actives and negatively charged filler improves oral product stability while enabling release in the mouth.

Localized hydrogel delivery of CAR-T cells, IL-15 nanoparticles, and platelet-bound aPDL1 helps prevent recurrence while limiting systemic side effects.

Acidic amino acid counterions in histidine, tris, or arginine formulations suppress antibody aggregation and support stable subcutaneous storage.

Porous silicon nanoparticles with isothiocyanate generate intracellular ROS without external initiators, enabling targeted drug release with low toxicity.

Cryogenic homogenization and jet milling create pure, reproducible cannabinoid nanoparticles for beverage compositions with GMP-ready processing.

A low-molecular-weight dual mTORC1/mTORC2 inhibitor activates autophagy, reduces Aβ and neuroinflammation, and restores cognitive function.

A phospholipid solid dispersion of ursolic acid potassium salt improves gastric-fluid solubility for practical oral nutraceutical formulations.

A phospholipid-clay complex improves poorly soluble drug release in the gut, boosting oral bioavailability while maintaining controlled release.

Xanthan gum keeps water-insoluble Urolithin A suspended after reconstitution, improving beverage stability without off-taste or odor.

Local intradermal or intraepidermal HfO2 nanoparticles modulate neuronal activity to relieve neuropathic pain with fewer side effects.

High-silicon hollow borosilicate microparticles create a uniform dark bowel lumen on CT while minimizing false iodine signals.

Replacing ascorbic acid with gentisic acid or related radioprotectants helps tetrofosmin kits keep stability, purity, and shelf-life.

Blocking excessive CGRP signaling in NEHI helps restore endothelial integrity, reduce pulmonary edema, and improve gas exchange.

Combining mesenchymal stem cell culture supernatant with site-specific nerve stimulation improves nerve disorder treatment efficacy.

A split-release gamma-hydroxybutyrate formulation matches twice-nightly exposure in one dose while improving bioavailability and lowering sodium intake.

A 15-40 nm carrier and embedded protective layer keep the enzyme stable while driving unexpected lung accumulation for lung cancer therapy.

Targeted gold nanoparticles boost photoacoustic detection of small bladder tumors while enabling localized photothermal therapy.

A lyophilized ActRIIa-Fc fusion protein formulation targets activin signaling to reduce vascular remodeling and muscularization in pulmonary hypertension.

Acetyl glucosamine improves cognition by lowering EXT1 and highly sulfated heparan sulfate while reducing memory deficits and seizure risk.

Modular branched ionizable lipids create flared nanoparticles that improve nucleic acid and peptide delivery without overly complex synthesis.

Glass microspheres tuned with Y2O3, BaO, and Ta2O5 improve X-ray visibility during embolization while keeping density suitable for uniform delivery.

Alginate and ammonium citrate stabilize nicotine in high-water oral or nasal compositions while preserving controlled release and shelf life.

Respirable dry powder surfactants use proteins, phospholipids, and desiccant packaging to enable stable inhalation delivery without intubation.

Metal-ion crosslinked alginate particles inactivate residual antibiotics across biological and environmental media with high specificity.

Wet ball milling creates a 100-300 nm progerinin nanosuspension that improves dispersibility, stability, and oral absorption.

Combining ITF2357 with glucocorticoids reduces inflammation while delaying muscle degeneration and improving fatigue resistance in muscular dystrophy.

Selective RXRβ-binding molecules target tumor-associated macrophages to reduce immunosuppression and improve targeted cancer treatment.

Lactate salts in lyophilized mRNA lipid nanoparticles reduce hydrolysis, speed reconstitution, and extend storage beyond cold-chain limits.

Etilefrine and diltiazem compositions inhibit influenza replication by modulating host cell pathways, enabling broad-spectrum activity across subtypes.

pH-sensitive nanoparticles protect proteins and peptides in the stomach, then release them in the intestine for oral delivery.

Fine-particle intranasal DHE powder with microcrystalline cellulose enables fast migraine relief while improving delivery consistency.

Ammonia converts curcumin into a stable, water-soluble ammonium phenoxide that improves bioavailability without complex delivery systems.

A lyophilized tubulysin conjugate formulation improves aqueous stability and shelf life while helping reduce liver toxicity before administration.

Controlling microsphere shape to 5% non-spherical or less and average size to 25-40 μm improves tumor distribution while reducing adverse reactions.

An inorganic core links multiple immunoglobulins with a penetration enhancer to synchronize tumor delivery and improve HER2 cancer response.

A binary lactose carrier in a capsule dry powder inhaler maintains respirable delivery of a PDE4 inhibitor while avoiding ternary-agent burden.

Controlled residual moisture and multi-excipient lyophilization keep therapeutic proteins stable at room temperature with minimal degradation.